GLP-1 RA vs DPP-4i Reduces Major CV, Kidney Risks in Lupus With Diabetes
GLP-1 RA vs DPP-4i Reduces Major CV, Kidney Risks in Lupus With Diabetes A trial emulation assessed the impact of GLP-1RA use on cardiovascular, kidney, and death outcomes in patients with…